UCLA researchers discover drug resistance mechanisms in most common form of melanoma

Researchers with UCLA's Jonsson Comprehensive Cancer Centre have found that melanoma patients whose cancers are caused by mutation of the BRAF gene become resistant to a promising targeted treatment through another genetic mutation or the overexpression of a cell surface protein, both driving survival of the cancer and accounting for relapse...

Read the whole article on

More from